KENYA –Kenya cancer stakeholders have proposed recommendations that address existing gaps in cancer care to enhance capacity of the public sector to better address emerging cancer challenges. The stakeholders outlined…
Read MoreTag: cancer risk screening test
23andMe gets FDA clearance for prostate cancer biomarker
USA – 23andMe, a genetic testing company, has announced that its prostate cancer risk test has been approved by the Food and Drug Administration. It’s 23andMe’s third cancer risk report…
Read More